# Marie Wislez

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marie-wislez/

## Facts

| Field | Value |
| --- | --- |
| Citations | 14,057 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 62 |
| i10-index | 176 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5053712155 |
| ORCID iD | 0000-0001-7518-7859 |
| Works | 635 |

## Researcher papers

- [Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures](https://scholariq.org/papers/long-term-survival-for-patients-with-non-small-cell-lung-cancer-with/)
- [Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic Perspectives](https://scholariq.org/papers/lung-cancer-that-harbors-an-i-her2-i-mutation-epidemiologic-characteristics-and/)
- [Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer](https://scholariq.org/papers/intratumoural-heterogeneity-generated-by-notch-signalling-promotes-small-cell/)
- [Primary pulmonary lymphoma](https://scholariq.org/papers/primary-pulmonary-lymphoma/)
- [Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility](https://scholariq.org/papers/nfib-promotes-metastasis-through-a-widespread-increase-in-chromatin/)
- [<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma](https://scholariq.org/papers/i-tp53-stk11-i-and-i-egfr-i-mutations-predict-tumor-immune-profile-and-the/)
- [Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort](https://scholariq.org/papers/lung-cancer-patients-with-her2-mutations-treated-with-chemotherapy-and-her2/)
- [Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network](https://scholariq.org/papers/rare-egfr-exon-18-and-exon-20-mutations-in-non-small-cell-lung-cancer-on-10-117/)
- [Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.](https://scholariq.org/papers/hepatocyte-growth-factor-production-by-neutrophils-infiltrating/)
- [Mutations in <i>COPA</i> lead to abnormal trafficking of STING to the Golgi and interferon signaling](https://scholariq.org/papers/mutations-in-i-copa-i-lead-to-abnormal-trafficking-of-sting-to-the-golgi-and/)
- [Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study](https://scholariq.org/papers/histomolecular-resistance-mechanisms-to-first-line-osimertinib-in-egfr-mutated/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.